149 related articles for article (PubMed ID: 21283697)
21. An integrated in-silico approach for drug target identification in human pathogen Shigella dysenteriae.
Qureshi H; Basheer A; Sajjad W; Faheem M; Babar Jamal S
PLoS One; 2024; 19(5):e0303048. PubMed ID: 38753867
[TBL] [Abstract][Full Text] [Related]
22. Lectins in fruits having gastrointestinal activity: their participation in the hemagglutinating property of Escherichia coli O157:H7.
Coutiño-Rodríguez R; Hernández-Cruz P; Giles-Ríos H
Arch Med Res; 2001; 32(4):251-7. PubMed ID: 11440778
[TBL] [Abstract][Full Text] [Related]
23. Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, α-amylase inhibition, and retardation of glucose absorption.
Ansari P; Afroz N; Jalil S; Azad SB; Mustakim MG; Anwar S; Haque SM; Hossain SM; Tony RR; Hannan JM
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):37-47. PubMed ID: 28002030
[TBL] [Abstract][Full Text] [Related]
24. Aegle marmelos fruit extract attenuates isoproterenol-induced oxidative stress in rats.
Krushna GS; Kareem MA; Reddy VD; Padmavathi P; Hussain SA; Devi Kodidhela L
J Clin Biochem Nutr; 2012 May; 50(3):199-204. PubMed ID: 22573921
[TBL] [Abstract][Full Text] [Related]
25. A novel mannose-binding lectin from Liparis nervosa with anti-fungal and anti-tumor activities.
Jiang N; Wang Y; Zhou J; Zheng R; Yuan X; Wu M; Bao J; Wu C
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1081-1092. PubMed ID: 32852549
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.
Manda VK; Avula B; Chittiboyina AG; Khan IA; Walker LA; Khan SI
Xenobiotica; 2016; 46(2):117-25. PubMed ID: 26247834
[TBL] [Abstract][Full Text] [Related]
27. Antidiarrhoeal evaluation of Aegle Marmelos (Correa) Linn. root extract.
Mazumder R; Bhattacharya S; Mazumder A; Pattnaik AK; Tiwary PM; Chaudhary S
Phytother Res; 2006 Jan; 20(1):82-4. PubMed ID: 16397850
[TBL] [Abstract][Full Text] [Related]
28. Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach.
Jalal K; Abu-Izneid T; Khan K; Abbas M; Hayat A; Bawazeer S; Uddin R
Sci Rep; 2022 Jan; 12(1):251. PubMed ID: 34997046
[TBL] [Abstract][Full Text] [Related]
29. In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins.
Willer Eda M; Lima Rde L; Giugliano LG
BMC Microbiol; 2004 Apr; 4():18. PubMed ID: 15115555
[TBL] [Abstract][Full Text] [Related]
30. Nalidixic-acid-resistant Shigella dysenteriae I.
Panhotra BR; Desai B; Sharma PL
Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
[No Abstract] [Full Text] [Related]
31. Comprehensive chemo-profiling of coumarins enriched extract derived from
Tiwari R; Mishra S; Danaboina G; Pratap Singh Jadaun G; Kalaivani M; Kalaiselvan V; Dhobi M; Raghuvanshi RS
Saudi Pharm J; 2023 Sep; 31(9):101708. PubMed ID: 37564748
[No Abstract] [Full Text] [Related]
32. Screening chemical inhibitors for alpha-amylase from leaves extracts of
Sangilimuthu AY; Sivaraman T; Chandrasekaran R; Sundaram KM; Ekambaram G
J Complement Integr Med; 2020 Aug; 18(1):51-57. PubMed ID: 32745070
[TBL] [Abstract][Full Text] [Related]
33. An outbreak of bacillary dysentery caused by quinolone-resistant Shigella dysenteriae type 1 in a northeastern state of India.
Niyogi SK; Sarkar K; Lalmalsawma P; Pallai N; Bhattacharya SK
J Health Popul Nutr; 2004 Mar; 22(1):97. PubMed ID: 15190817
[No Abstract] [Full Text] [Related]
34. Adherence of Shigella dysenteriae 1 to human colonic mucin.
Sudha PS; Devaraj H; Devaraj N
Curr Microbiol; 2001 Jun; 42(6):381-7. PubMed ID: 11381327
[TBL] [Abstract][Full Text] [Related]
35. Increase in multiresistance of Shigella dysenteriae type 1 strain in Rwanda.
Mutwewingabo A; Mets T
East Afr Med J; 1987 Dec; 64(12):812-5. PubMed ID: 3333152
[No Abstract] [Full Text] [Related]
36. Anti adipogenic activity of Aegle marmelos Correa.
Karmase A; Jagtap S; Bhutani KK
Phytomedicine; 2013 Nov; 20(14):1267-71. PubMed ID: 23972792
[TBL] [Abstract][Full Text] [Related]
37. Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats.
Mudi SR; Akhter M; Biswas SK; Muttalib MA; Choudhury S; Rokeya B; Ali L
J Complement Integr Med; 2017 Mar; 14(2):. PubMed ID: 28284036
[TBL] [Abstract][Full Text] [Related]
38. Process optimization for spray dried Aegle marmelos fruit nanomucilage: Characterization, functional properties, and in vitro antibiofilm activity against food pathogenic microorganisms.
Sharma M; Bains A; Sridhar K; Chawla P; Sharma M
Int J Biol Macromol; 2023 Sep; 249():126050. PubMed ID: 37517760
[TBL] [Abstract][Full Text] [Related]
39. Oviposition-deterrent, ovicidal, and repellent activities of indigenous plant extracts against Anopheles subpictus Grassi (Diptera: Culicidae).
Elango G; Bagavan A; Kamaraj C; Abduz Zahir A; Abdul Rahuman A
Parasitol Res; 2009 Nov; 105(6):1567-76. PubMed ID: 19707789
[TBL] [Abstract][Full Text] [Related]
40. In vivo and molecular docking studies using whole extract and phytocompounds of Aegle marmelos fruit protective effects against Isoproterenol-induced Myocardial infarction in rats.
Krushna GS; Shivaranjani VL; Umamaheswari J; Srinivasulu C; Hussain SA; Kareem MA; Reddy VD; Ali D; Lokhande KB; Swamy KV; Kodidhela LD
Biomed Pharmacother; 2017 Jul; 91():880-889. PubMed ID: 28511341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
